Lower admission hemoglobin levels are associated with longer symptom duration in acute st-elevation myocardial infarction

Clinical Cardiology

Volumn 37, Issue 2, 2014, Pages 73-77

  Shacham, Yacov ^a   Leshem Rubinow, Eran ^a   Ben Assa, Eyal ^a   Roth, Arie ^a   Steinvil, Arie ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; EMERGENCY SERVICE, HOSPITAL; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84893907849     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22215     Document Type: Article

References (26)

1. Nikolsky E, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol. 2004; 44: 547-553. (Pubitemid 39078177)
2. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005; 111: 2042-2049. (Pubitemid 40577898)
3. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007; 116: 2793-2801. (Pubitemid 350291221)
4. Giugliano RP, Giraldez RR, Morrow DA, et al. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the EXTRACT-TIMI 25 trial. Eur Heart J. 2010; 31: 2103-2110.
5. Bassand JP, Afzal R, Eikelboom J, et al. for OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010; 31: 50-58.
6. Salisbury AC, Alexander KP, Reid KJ, et al. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010; 3: 337-346.
7. James SK, Oldgren J, Lindbäck J, et al. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J. 2005; 149: 619-626.
8. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009; 113: 5277-5286.
9. Keel SB, Abkowitz JL,. The microcytic red cell and the anemia of inflammation. N Engl J Med. 2009; 361: 1904-1906.
10. Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med. 2005; 352: 1011-1023.
11. Steinvil A, Banai S, Leshem-Rubinow E, et al. The development of anemia of inflammation during acute myocardial infarction. Int J Cardiol. 2012; 156: 160-164.
12. Steinvil A, Rogowski O, Banai S, et al. Anemia and inflammation have an additive value in risk stratification of patients undergoing coronary interventions. J Cardiovasc Med (Hagerstown). 2013; doi:10.2459/JCM. 0b013e32836380b4.
13. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61: e78-e140.
14. Arbel Y, Eros Y, Rogowski O, et al. Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography. Am J Cardiol. 2007; 99: 1504-1506. (Pubitemid 46783802)
15. Bolińska S, Sobkowicz B, Zaniewska J, et al. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol. 2011; 69: 33-39.
16. Ayhan E, Aycicek F, Uyarel H, et al. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes. Coron Artery Dis. 2011; 22: 375-379.
17. Aronson D, Suleiman M, Agmon Y, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J. 2007; 28: 1289-1296. (Pubitemid 47355975)
18. Dündar C, Oduncu V, Erkol A, et al. In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol. 2012; 101: 37-44.
19. Vrsalovic M, Pintaric H, Babic Z, et al. Impact of admission anemia, C-reactive protein and mean platelet volume on short term mortality in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Clin Biochem. 2012; 45: 1506-1509.
20. Meisinger C, Heier M, von Scheidt W, et al. MONICA/KORA Myocardial Infarction Registry. Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction. Clin Res Cardiol. 2010; 99: 817-823.
21. Kuch B, von Scheidt W, Kling B, et al. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry). Am J Cardiol. 2008; 102: 1125-1130.
22. Griffiths JD, Campbell LJ, Woodruff IW, et al. Acute changes in iron metabolism following myocardial infarction. Am J Clin Pathol. 1985; 84: 649-654. (Pubitemid 16235306)
23. van der Schouw YT, van der Veeken PM, Kok FJ, et al. Iron status in the acute phase and six weeks after myocardial infarction. Free Radic Biol Med. 1990; 8: 47-53.
24. Lev EI, Kornowski R, Vaknin-Assa H, et al. Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2009; 103: 165-169.
25. Dominguez-Rodriguez A, Samimi-Fard S, Abreu-Gonzalez P, et al. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am J Cardiol. 2008; 101: 1537-1540.
26. van Diepen S, Roe MT, Lopes RD, et al. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. J Thromb Thrombolysis. 2012; 34: 106-113.